Loading organizations...
Loading organizations...
Cancer therapeutics company developing dual-action drugs for tumors.
Trio Pharmaceuticals has raised $5.3M across 2 funding rounds.
Trio Pharmaceuticals has raised $5.3M in total across 2 funding rounds.
Trio Pharmaceuticals has raised $5.3M in total across 2 funding rounds.
Trio Pharmaceuticals's investors include Friedman BioVentures.
Trio Pharmaceuticals has raised $5.3M across 2 funding rounds. Most recently, it raised $3.1M Pre-Series A in December 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 3, 2024 | $3.1M Pre-Series A | Friedman BioVentures | |
| Apr 28, 2023 | $2.2M Seed |